Bada Kang1,2, Hanzhang Xu1,3, Eleanor S McConnell1,2. 1. School of Nursing, Duke University, Durham, NC, USA. 2. Geriatric Research, Education and Clinical Center (GRECC), Durham Department of Veterans Affairs (VA) Medical Center, Durham, NC, USA. 3. Department of Community and Family Medicine, Duke University, Durham, NC, USA.
Abstract
OBJECTIVES: Posttraumatic stress disorder (PTSD) is associated with neurocognitive and psychiatric comorbidities, and older adults experience comorbid illnesses disproportionately. Little is known about the comorbidities of PTSD among older veterans. This systematic review examines the prevalence, incidence, and patterns of neurocognitive and psychiatric comorbidities of PTSD among older veterans and explores the factors associated with these comorbidities. METHODS: A systematic literature review was performed using PubMed, CINAHL, and PsycINFO databases. The search was limited to peer-reviewed articles published in English from January 1980 to October 2018. Eligible studies examined the comorbid neurocognitive and psychiatric disorders of PTSD among veterans aged 60 and older. RESULTS: Twenty-four studies met the criteria for inclusion. The risk for dementia was higher in veterans with PTSD than those without PTSD; hazard ratios ranged from 1.21 to 1.77. Depressive disorder was the most prevalent psychiatric comorbidity with estimates ranging from 33% to 52.3%, followed by generalized anxiety disorder (14%-15%) and substance use disorders (1.9%-11.3%). Factors consistently associated with PTSD comorbidities included age, combat-related exposures, clinical conditions, and health-related and psychosocial outcomes. CONCLUSIONS: Despite heterogeneity in research designs and methodological limitations, this review highlights the need to consider comorbid neurocognitive and psychiatric disorders among older veterans with PTSD in order to individualize care approaches. Future research should incorporate factors associated with neurocognitive and psychiatric comorbidities of PTSD into study designs that can help improve prediction of comorbidity and generate evidence for developing and implementing tailored treatments in older veterans.
OBJECTIVES:Posttraumatic stress disorder (PTSD) is associated with neurocognitive and psychiatric comorbidities, and older adults experience comorbid illnesses disproportionately. Little is known about the comorbidities of PTSD among older veterans. This systematic review examines the prevalence, incidence, and patterns of neurocognitive and psychiatric comorbidities of PTSD among older veterans and explores the factors associated with these comorbidities. METHODS: A systematic literature review was performed using PubMed, CINAHL, and PsycINFO databases. The search was limited to peer-reviewed articles published in English from January 1980 to October 2018. Eligible studies examined the comorbid neurocognitive and psychiatric disorders of PTSD among veterans aged 60 and older. RESULTS: Twenty-four studies met the criteria for inclusion. The risk for dementia was higher in veterans with PTSD than those without PTSD; hazard ratios ranged from 1.21 to 1.77. Depressive disorder was the most prevalent psychiatric comorbidity with estimates ranging from 33% to 52.3%, followed by generalized anxiety disorder (14%-15%) and substance use disorders (1.9%-11.3%). Factors consistently associated with PTSD comorbidities included age, combat-related exposures, clinical conditions, and health-related and psychosocial outcomes. CONCLUSIONS: Despite heterogeneity in research designs and methodological limitations, this review highlights the need to consider comorbid neurocognitive and psychiatric disorders among older veterans with PTSD in order to individualize care approaches. Future research should incorporate factors associated with neurocognitive and psychiatric comorbidities of PTSD into study designs that can help improve prediction of comorbidity and generate evidence for developing and implementing tailored treatments in older veterans.
Authors: Natalie G Regier; Aanand D Naik; Elizabeth A Mulligan; Ziad S Nasreddine; Jane A Driver; Yvonne H-F Sada; Jennifer Moye Journal: Psychooncology Date: 2019-06-13 Impact factor: 3.894
Authors: Sascha Halvachizadeh; Henrik Teuber; Till Berk; Florin Allemann; Roland von Känel; Boris Zelle; Paolo Cinelli; Hans-Christoph Pape; Roman Pfeifer Journal: PLoS One Date: 2020-05-04 Impact factor: 3.240
Authors: Karen A Lawrence; Theresia M Pachner; Molly M Long; Stephanie Henderson; Donna L Schuman; Brenda L Plassman Journal: BMJ Open Date: 2020-06-03 Impact factor: 2.692
Authors: Alison E Willing; Sue Ann Girling; Ryan Deichert; Rebecca Wood-Deichert; Jason Gonzalez; Diego Hernandez; Elspeth Foran; Paul R Sanberg; Kevin E Kip Journal: Mil Med Date: 2019-12-01 Impact factor: 1.437
Authors: Marcin Rzeszutek; Maja Lis-Turlejska; Aleksandra Krajewska; Amelia Zawadzka; Michał Lewandowski; Szymon Szumiał Journal: Front Psychol Date: 2020-02-26